Morphological and molecular heterogeneity in colorectal neoplasms with K-RAS mutation. A report of two cases

Pathology Research and Practice

Volumn 207, Issue 6, 2011, Pages 399-402

  Bösmüller, Hans ^a   Kranewitter, Wolfgang ^a   Webersinke, Gerald ^a   Rumpold, Holger ^a   Hackl, Margit ^b   Fend, Falko ^c  

^a Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Colorectal cancer; Heterogeneity; K RAS; Signet ring cell carcinoma

Indexed keywords

K RAS PROTEIN;

ADULT; ARTICLE; ASCITES; CANCER GRADING; CANCER GROWTH; CANCER MORPHOLOGY; CASE REPORT; COLON POLYP; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; GENE ACTIVATION; GENE MUTATION; GENETIC HETEROGENEITY; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; MUTATIONAL ANALYSIS; PREDICTION; RECTUM TUMOR; SIGNET RING CARCINOMA; TUMOR BIOPSY;

ADULT; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRODISSECTION; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MUTATION; PHENOTYPE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79958721188     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.03.004     Document Type: Article

References (33)

1. Al-Mulla F., Going G.G., Sowden E.T., Winter A., Pickford I.R., Birnie G.D. Heterogeneity of mutant versus wild type K-Ras in primary and metastatic colorectal carcinomas, and association of codon 12 Valine with early mortality. J. Pathol. 1998, 185:130-138.
2. Andreyev H., Norman A., Cunningham D., Oates J., Clarke P. Kirsten ras mutations in patients with colorectal cancer: the multicenter " RASCAL" study. J. Natl. Cancer Inst. 1998, 90:675-684.
3. Andreyev H., Tilsed J., Cunningham D., et al. K-ras mutations in patients with early colorectal cancers. Gut 1997, 41:323-329.
4. Artale S., Sartore-Bianchi A., Veronese S.M., Gambi V., Sarnataro C.S., et al. Mutations of K-Ras and B-Raf in Primary and Matched Metastatic Sites of Colorectal Cancer. J. Clin. Oncol. 2008, 26:4217-4219.
5. Baisse B., Bouzourene H., Saraga E.P., Bosman F.T., Benhattar J. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int. J. Cancer 2001, 93(3):346-352.
6. Baldus S.E., Schaefer K.L., Engers R., Hartleb D., Stoecklein N.H., Gabbert H.E. Prevalence and heterogeneity of K-Ras B-Raf, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin. Cancer Res. 2010, 16:790-799.
7. Bazan V., Migliavacca M., Zanna I., et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann. Oncol. 2002, 13:1438-1446.
8. Conlin A., Smith G., Carey F., Wolf C., Steele R. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 2005, 54:1283-2126.
9. Etienne-Grimaldi M.C., Formento J.L., Francoual M., Francois E., Formento P., Renée N., Laurent-Puig P., et al. K-Ras mutations and treatment in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. Clin. Cancer Res. 2008, 14:4830-4835.
10. Fearon E. Molecular genetic studies of the adenoma-carcinoma sequence. Adv. Intern. Med. 1994, 39:123-147.
11. Finkelstein S.D., Sayegh R., Christenden S., Swalsky P.A. Genotypic classification of colorectal adenocarcinoma. Cancer 1993, 71:3827-3838.
12. Gattenlohner S., Germer C., Müller-Hermelink H.K. Commentary on Karapetis et al: K-Ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 2009, 360:835.
13. Giaretti W., Macciou B., Geido E., Hermsen M., Postma C., Baak J., Williams R., Meijer G. Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer. Anal. Cell Pathol. 2000, 21:449-457.
14. Giaretti W., Monaco R., Pujic N., Rapallo A., Nigro S., Geido E. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. Am. J. Pathol. 1996, 149:237-245.
15. Ishii M., Sugai T., Habano W., et al. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas. J. Gastroenterol. 2004, 39:544-549.
16. Karapetis C.S., Khanbara-Ford S., Jonker D.J., O'Callaghan C.T., Tu D., Tebbutt N.C., et al. K-Ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 2008, 359:1757-1765.
17. Kawabata Y., Tomita N., Monden T., Ohue M., Ohnishi T., Sasaki M., Sekimoto M., Sakita I., Tamaki Y., Takahashi J., Yagyu T., Mishima H., Kikkawa N., Monden M. Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int. J. Cancer 1999, 84(1):33-38.
18. Keller G., Geist B., Slotta-Huspenina J., Langer R., Nagl F., Fend F., Höfler H., Perren A. Novel multiple, monoallelic KRAS mutations at codon 12 and 13. Int. J. Cancer 2009, 125:2744-2745.
19. Kimura K., Nagasaka T., Hoshizima N., Sasamoto H., Notohara K., Takeda M., Kominami K., Iishii T., Tanaka N., Matsubara N. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations. J. Int. Med. Res. 2007, 35:450-457.
20. van Krieken J., Jung A., Kirchner T., Carneiro F., Seruca R., Bosman F., Quirke P., Fléjou J., Plato Hansen T., de Hertogh G., Jares P., Langner C., Hoefler G., Ligtenberg M., Tiniakos D., Tejpar S., Bevilacqua G., Ensari A. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch. 2008, 453:417-431.
21. Lievre A., Bachet J., Le C.D., Boige V., Landi B., Emile J., Cote J., Tomasic G., Penna C., Ducreux M., Rougier P., Penault-Llorca F., Laurent-Puig P. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 2006, 66:3992-3995.
22. Losi L., Baisse B., Bouzourene H., Benhattar J. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005, 26:916-922.
23. Moerkerk P., Arends J.W., van Driel M., De Bruine A., de Goeij A., ten Kate J. Type and number of K-Ras point mutations relate to stage of human colorectal cancer. Cancer Res. 1994, 54:3376-3378.
24. Oliveira C., Velho S., Moutinho C., Ferreira A., Preto A., Domingo E., Capelinha A.F., Duval A., et al. K-Ras and B-Raf oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 2007, 26:158-163.
25. Santini D., Loupakis F., Vincenzi B., et al. High concordance of K-Ras status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist 2008, 13:1270-1275.
26. Sasaki S., Masaki T., Umetani N., Futakawa N., Ando H., Muto T. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn. J. Clin. Oncol. 1998, 28:202-206.
27. Shivapurkar N., Huang L., Ruggeri B., et al. K-ras and p53 mutations in abberant crypt foci and colonic tumors from colon cancer patients. Cancer Lett. 1997, 115:39-46.
28. Span M., Moerkerk P.T., de Geij F.P., Arends J.W. A detailed analyses of K-Ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int. J. Cancer 1996, 69:241-245.
29. Tortola S., Steinert R., Hantschik M., Peinado M.A., Gastinger I., Stosiek P., Lippert H., Schlegel W., Reymond M.A. Discordance between K-Ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. J. Clin. Oncol. 2001, 19:2837-2843.
30. Vogelstein B., Fearon E., Kern S. Allelotype of colorectal carcinomas. Science 1989, 244:207-211.
31. Wistuba I., Behrens C., Albores-Saavedra J., Delgado R., Lopez F., Gazdar A. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma. Clin. Cancer Res. 2003, 9:3615-3619.
32. Yuan P., Sun M., Zhang J., Zhu X., Shi D. APC and K-ras gene mutation in abberant crypt foci of human colon. World J. Gastroenterol. 2001, 7:352-356.
33. Zauber P., Sabbath-Solitare M., Marotta S.P., Bishop D.T. Molecular changes in the K-Ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas. Mol. Pathol. 2003, 56:137-140.